Skip Navigation
National Institute of Environmental Health SciencesNational Institutes of Health
Increase text size Decrease text size Print this page

SELAM

  • Principal Investigator:

    Ernest Choy, King's College, London
  • Study Design:

    Phase 2, Randomized placebo controlled, factorial multicenter, Europe
  • Types & Number of IIM Studied:

    Active polymyositis or dermatomyositis (N = 92)
  • Entry Criteria:

    Probable or definite Bohan and Peter criteria for polymyositis or dermatomyositis
  • IMACS Core Set Measures Included:

    Patient and Physician global activity, Manual Muscle Testing, CK, Myositis Disease Activity Assessment Tool (MITAX); Health Related Quality of Life by SF-36
  • Other Measures Included:

    Modified ALS rating scale, steroid dose
  • Primary Outcome:

    15% Manual Muscle Testing, 15% Functional Improvement
  • Study Duration:

    12 months
  • Funding:

    Arthritis Research Campaign
  • Comments:

    Started 2/2002
  • Contact:

    Barbara Mason Tel: 0207 848 5791 Fax: 0207 848 5754 Email: barbara.mason@kcl.ac.uk

Return to Therapeutic Studies listing

USA.gov Department of Health & Human Services National Institutes of Health
This page URL: http://www.niehs.nih.gov/research/resources/collab/imacs/therapeutic_study3.cfm
NIEHS website: http://www.niehs.nih.gov/
Email the Web Manager at webmanager@niehs.nih.gov
Last Reviewed: October 30, 2007